Luca Bortolussi
ABSTRACT
We consider rule-based models extended with time-dependent reaction rates, a suitable formalism to describe the effect of drug administration on biochemical systems. In the paper, we provide a novel and efficient rejection-based simulation algorithm that samples exactly the trajectory space of such models. Furthermore, we investigate a model of drug administration in the context of a plaque-formation process of Alzheimer's disease, a polymerization process best described by a rule-based model to counteract the intrinsic combinatorial explosion of the underlying reaction network. Furthermore, time-dependent rates are needed to model the effect of drugs. We apply the simulation algorithm to study the efficacy of different drug administration policies.
- H. H. McAdams and A. Arkin. Stochastic mechanisms in gene expression. PNAS, 94(3):814--819, 1997.Google Scholar
Cross Ref
- P. S. Swain, M. B. Elowitz, and E. D. Siggia. Intrinsic and extrinsic contributions to stochasticity in gene expression. PNAS, 99(20):12795--12800, 2002.Google ScholarCross Ref
- H. Tobita. Simulation model for the modification of polymers via crosslinking and degradation. Polymer, 36(13):2585--2596, 1995.Google ScholarCross Ref
- D. T. Gillespie. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. Journal of Computational Physics, 22:403--434, 1976.Google ScholarCross Ref
- D. T Gillespie. Exact stochastic simulation of coupled chemical reactions. The journal of physical chemistry, 81(25):2340--2361, 1977.Google Scholar
- M. A. Gibson and J. Bruck. Efficient exact stochastic simulation of chemical systems with many species and many channels. The journal of physical chemistry A, 104(9):1876--1889, 2000.Google Scholar
- M. Rathinam, L. R. Petzold, Y. Cao, and D. T Gillespie. Stiffness in stochastic chemically reacting systems: The implicit tau-leaping method. The Journal of Chemical Physics, 119(24):12784--12794, 2003.Google ScholarCross Ref
- V. Danos, J. Feret, W. Fontana, R. Harmer, and J. Krivine. Rule-based modelling of cellular signalling. Lect Note Comput Sci, 4703:17--41, 2007. Google ScholarDigital Library
- J. R. Faeder, M. L. Blinov, B. Goldstein, and W. S. Hlavacek. Rule-based modeling of biochemical networks. Complexity, 10:22--41, 2005. Google ScholarDigital Library
- F. RD van Parijs, K. Morreel, J. Ralph, W. Boerjan, and R. MH Merks. Modeling lignin polymerization. i. simulation model of dehydrogenation polymers. Plant physiology, 153(3):1332--1344, 2010.Google ScholarCross Ref
- M. W. Sneddon, J. R. Faeder, and T. Emonet. Efficient modeling, simulation and coarse-graining of biological complexity with nfsim. Nature Methods, 8:177--185, 2011.Google ScholarCross Ref
- V. Danos, J. Feret, W. Fontana, and J. Krivine. Scalable simulation of cellular signaling networks. In Programming Languages and Systems, pages 139--157. Springer, 2007. Google ScholarCross Ref
- J. Yang, M. I. Monine, J. R. Faeder, and W. S. Hlavacek. Kinetic monte carlo method for rule-based modeling of biochemical networks. Physical Review E, 78(3):031910, 2008.Google ScholarCross Ref
- C. Baier, J.-P. Katoen, H. Hermanns, and V. Wolf. Comparative branching-time semantics for markov chains. Information and computation, 200(2):149--214, 2005. Google ScholarDigital Library
- F. Zhang, M. Yeddanapudi, and P. Mosterman. Zero-crossing location and detection algorithms for hybrid system simulation. In IFAC World Congress, pages 7967--7972, 2008.Google ScholarCross Ref
- V. Holubec, P. Chvosta, M. Einax, and P. Maass. Attempt time monte carlo: An alternative for simulation of stochastic jump processes with time-dependent transition rates. EPL (Europhysics Letters), 93(4):40003, 2011.Google Scholar
- D. J. Selkoe. Toward a comprehensive theory for alzheimer's disease. Annals of the New York Academy of Sciences, 924(1):17--25, 2000.Google ScholarCross Ref
- I. Benilova, E. Karran, and B. De Strooper. The toxic Aβ oligomer and alzheimer's disease: an emperor in need of clothes. Nature neuroscience, 15(3):349--357, 2012.Google ScholarCross Ref
- D. L. Craft, L. M. Wein, and D. J. Selkoe. A mathematical model of the impact of novel treatments on the aβ burden in the alzheimers brain, csf and plasma. Bulletin of mathematical biology, 64(5):1011--1031, 2002.Google Scholar
- K. G. Haug, A. Staab, C. Dansirikul, and T. Lehr. A semi-physiological model of amyloid-β biosynthesis and clearance in human cerebrospinal fluid. The Journal of Clinical Pharmacology, 53(7):691--698, 2013.Google ScholarCross Ref
- P. A. Lewis and G. S. Shedler. Simulation of nonhomogeneous poisson processes by thinning. Naval Research Logistics Quarterly, 26(3):403--413, 1979.Google ScholarCross Ref
- V. H. Thanh, C. Priami, and R. Zunino. Efficient rejection-based simulation of biochemical reactions with stochastic noise and delays. The Journal of chemical physics, 141(13):134116, 2014.Google Scholar
- D. F. Anderson. A modified next reaction method for simulating chemical systems with time dependent propensities and delays. The Journal of chemical physics, 127(21):214107, 2007.Google Scholar
- J. Hardy and D. J. Selkoe. The amyloid hypothesis of alzheimer's disease: progress and problems on the road to therapeutics. Science, 297(5580):353--356, 2002.Google ScholarCross Ref
- R. J. Bateman, L. Y. Munsell, J. C. Morris, R. Swarm, K. E. Yarasheski, and D. M. Holtzman. Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nature medicine, 12(7):856--861, 2006.Google ScholarCross Ref
- R. J. Bateman, E. R. Siemers, K. G. Mawuenyega, G. Wen, K. R. Browning, W. C. Sigurdson, K. E. Yarasheski, S. W. Friedrich, R. B. DeMattos, P. C. May, et al. A γ-secretase inhibitor decreases amyloid-β production in the central nervous system. Annals of neurology, 66(1):48--54, 2009.Google ScholarCross Ref
- Rule-based modelling and simulation of drug-administration policies
Recommendations
Pharmacoinformatic Analysis of Drug Leads for Alzheimer’s Disease from FDA-Approved Dataset Through Drug Repositioning Studies
Bioinformatics and Biomedical EngineeringAbstractDrug design is highly priced and time-consuming procedure. Therefore, to overcome this problem, in silico drug design methods, particularly drug repositioning have been developed to assess therapeutic effects of known drugs against other diseases. ...
Drug Repurposing: Targeting mTOR Inhibitors for Anticancer Activity
CSBio '17: Proceedings of the 8th International Conference on Computational Systems-Biology and BioinformaticsIn the search of safer and more effective drugs while reducing costs and increasing productivity of novel drug discovery, scientists are changing their focus to an approach known as drug repurposing. This involves finding a new therapeutic effect of an ...
Simulation of large-scale rule-based models
Motivation: Interactions of molecules, such as signaling proteins, with multiple binding sites and/or multiple sites of post-translational covalent modification can be modeled using reaction rules. Rules comprehensively, but implicitly, define the ...
Comments